UCI Health clinicians have launched a clinical trial to test the efficacy of the antiviral drug remdesivir as a potential therapy for COVID-19, the disease caused by the novel coronavirus (SARS-CoV-2) that has reached pandemic levels across the globe. There are no specific therapeutics approved by the Food and Drug…
Partnering with five diagnostics manufacturers, UC San Diego is significantly ramping up testing for COVID-19, projecting capacity to complete up to 1,500 tests daily within two to three weeks.
With COVID-19 restrictions beginning to crimp the region’s blood supply, the UCI Health Blood Donor Center in Orange has expanded its hours of operation to six days a week to boost donations for its patients. The call for more donations comes as the American Red Cross announced a severe blood…
As the novel coronavirus spreads around the globe, the populations most vulnerable to the disease have been older adults and people with pre-existing conditions, such as heart or lung disease, diabetes or compromised immune systems. Data collected from known cases of COVID-19 indicate that people over age 60 are more…
The global outbreak of coronavirus disease 2019 (COVID-2019) is having an impact on the mental health of millions of people. Thanks to a 24-hour news cycle, near-constant social media use, empty store shelves and a flood of inaccurate information, reports of anxiety, fear and uncertainty are on the rise. These…
UC San Diego researchers discover the enzyme SPRK1’s role in reorganizing the paternal genome during the first moments of fertilization — a finding that might help explain infertility cases of unknown cause.
UC San Diego researchers discover the enzyme SPRK1’s role in reorganizing the paternal genome during the first moments of fertilization — a finding that might help explain infertility cases of unknown cause
Health Media Contacts
Find the best contact for health-related media inquiries.
